Deinove has chosen Processium to develop carotenoid separation/purification techniques at an industrial scale and to transpose the production process from the laboratory to industry. ###Deinove discovers, develops and produces high-value compounds from rare bacteria, notably from the Deinococcus genus.###It plans to market the carotenoids produced directly to the healthcare, nutrition and cosmetics industrials. ###This business is expected to start generating revenue in 2018.###In 2016, Deinove obtained proof of concept for the production of carotenoid molecules from optimized Deinococcus strains:###1. Five conventional molecules with known applications and identified markets;###2. One new molecule, Deinoxanthin, which must undergo characterization tests and a regulatory clearance before it can be marketed.###The company aims to market carotenoids in the form of ingredients directly to the industrials of its target markets.###It doesmagnesium citrate cherry not have plans to develop its own manufacturing facilities, but will subcontract production, including the large-scale fermentation, extraction, purification and formulcal mag citrate with vitamin d3ation stages.###With Deinove, Processium will be developing and validating an industrial process for extracting carotenoidmagnesium citrate for utis from magnesium citrate best pricethe fermentation medium to obtain a marketable product.###It will also identify and select subcontracmagnesium citrate for sleep reddittors that can start production quickly.